Atlas FDA

ORAQUICK HCV RAPID ANTIBODY TEST

FDA premarket approval P080027/S005 · decided 2011-07-27

Approval details

PMA number
P080027
Supplement
S005
Supplement type
135 Review Track For 30-Day Notice
Trade name
ORAQUICK HCV RAPID ANTIBODY TEST
Generic name
Assay, enzyme linked immunosorbent, hepatitis c virus
Applicant
OraSure Technologies, Inc.
Date received
2011-03-16
Decision date
2011-07-27
Days to decision
133 days
Decision code
APPR
Product code
MZO
Advisory committee
Microbiology
Expedited review
No
Location
Bethlehem, PA
Statement
APPROVAL FOR THE OPTION TO AUTOMATE THE MANUFACTURING PROCESS FOR ASSEMBLY OF THE ORAQUICK® HCV RAPID ANTIBODY TEST.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
OraQuick Ebola Rapid Antigen Test (DEN190025)OraSure Technologies, Inc.2019-10-10
COMPOUND W FREEZE OFF WART REMOVAL SYSTEM (K060859)OraSure Technologies, Inc.2006-07-18
HISTOFREEZER WART REMOVAL SYSTEM OR OTHER PROPRIETARY NAME (K023487)OraSure Technologies, Inc.2003-03-20
OTI BENZODIAZEPINES INTERCEPT MICRO-PLATE EIA MODEL #1110I (K013882)OraSure Technologies, Inc.2002-04-17
UPLINK TEST SYSTEM (K020371)OraSure Technologies, Inc.2002-04-03
INTERCEPT ORAL FLUID DRUG TEST ORAL SPECIMEN COLLECTION DEVICE, MODEL 503-XXXX (K011057)OraSure Technologies, Inc.2001-06-06
STC CANNABINOIDS INTERCEPT MICRO-PLATE EIA, MODEL 1118I (K002375)OraSure Technologies, Inc.2001-01-26
STC BARBITURATES INTERCEPT MICRO-PLATE EIA, MODEL 1108I (K001976)OraSure Technologies, Inc.2000-12-06